• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠-肌醇协同转运蛋白 1(SMIT1)介导高血糖诱导的心脏活性氧的产生。

Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.

机构信息

Université catholique de Louvain, Institut de Recherche Expérimentale et Clinique, Pôle de Recherche Cardiovasculaire, Brussels, Belgium.

Université catholique de Louvain, Institut de Recherche Expérimentale et Clinique, Pole of Pharmacology and Therapeutics, Brussels, Belgium.

出版信息

Sci Rep. 2017 Jan 27;7:41166. doi: 10.1038/srep41166.

DOI:10.1038/srep41166
PMID:28128227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5269587/
Abstract

Hyperglycemia (HG) stimulates the production of reactive oxygen species in the heart through activation of NADPH oxidase 2 (NOX2). This production is independent of glucose metabolism but requires sodium/glucose cotransporters (SGLT). Seven SGLT isoforms (SGLT1 to 6 and sodium-myoinositol cotransporter-1, SMIT1) are known, although their expression and function in the heart remain elusive. We investigated these 7 isoforms and found that only SGLT1 and SMIT1 were expressed in mouse, rat and human hearts. In cardiomyocytes, galactose (transported through SGLT1) did not activate NOX2. Accordingly, SGLT1 deficiency did not prevent HG-induced NOX2 activation, ruling it out in the cellular response to HG. In contrast, myo-inositol (transported through SMIT1) reproduced the toxic effects of HG. SMIT1 overexpression exacerbated glucotoxicity and sensitized cardiomyocytes to HG, whereas its deletion prevented HG-induced NOX2 activation. In conclusion, our results show that heart SMIT1 senses HG and triggers NOX2 activation. This could participate in the redox signaling in hyperglycemic heart and contribute to the pathophysiology of diabetic cardiomyopathy.

摘要

高血糖(HG)通过激活 NADPH 氧化酶 2(NOX2)刺激心脏中活性氧的产生。这种产生不依赖于葡萄糖代谢,但需要钠/葡萄糖协同转运蛋白(SGLT)。已知有 7 种 SGLT 同工型(SGLT1 至 6 和钠-肌醇协同转运蛋白-1,SMIT1),尽管它们在心脏中的表达和功能仍不清楚。我们研究了这 7 种同工型,发现只有 SGLT1 和 SMIT1 在小鼠、大鼠和人心肌中表达。在心肌细胞中,半乳糖(通过 SGLT1 转运)不会激活 NOX2。因此,SGLT1 缺乏并不能防止 HG 诱导的 NOX2 激活,这排除了它在细胞对 HG 反应中的作用。相比之下,肌醇(通过 SMIT1 转运)再现了 HG 的毒性作用。SMIT1 的过表达加剧了葡萄糖毒性作用,并使心肌细胞对 HG 敏感,而其缺失则阻止了 HG 诱导的 NOX2 激活。总之,我们的研究结果表明,心脏 SMIT1 感知 HG 并触发 NOX2 激活。这可能参与了高血糖心脏中的氧化还原信号转导,并有助于糖尿病心肌病的病理生理学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/841c7e147b3d/srep41166-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/9ef7c623cc86/srep41166-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/59c9a25a3942/srep41166-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/8a6c3fc1b325/srep41166-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/aa362a860abc/srep41166-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/c4dd968b5c54/srep41166-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/480374b79860/srep41166-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/841c7e147b3d/srep41166-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/9ef7c623cc86/srep41166-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/59c9a25a3942/srep41166-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/8a6c3fc1b325/srep41166-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/aa362a860abc/srep41166-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/c4dd968b5c54/srep41166-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/480374b79860/srep41166-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e76b/5269587/841c7e147b3d/srep41166-f7.jpg

相似文献

1
Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.钠-肌醇协同转运蛋白 1(SMIT1)介导高血糖诱导的心脏活性氧的产生。
Sci Rep. 2017 Jan 27;7:41166. doi: 10.1038/srep41166.
2
NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1.高血糖诱导心肌细胞 NADPH 氧化酶的激活不依赖于葡萄糖代谢,但需要 SGLT1。
Cardiovasc Res. 2011 Nov 1;92(2):237-46. doi: 10.1093/cvr/cvr230. Epub 2011 Aug 22.
3
AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes.胰高血糖素样肽-1 通过激活 AMPK 防止高血糖诱导的成年心肌细胞中 NADPH 氧化酶的激活。
Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1120-33. doi: 10.1152/ajpheart.00210.2014. Epub 2014 Aug 15.
4
TRPC6 counteracts TRPC3-Nox2 protein complex leading to attenuation of hyperglycemia-induced heart failure in mice.TRPC6 拮抗 TRPC3-Nox2 蛋白复合物,从而减轻小鼠高血糖诱导的心力衰竭。
Sci Rep. 2017 Aug 8;7(1):7511. doi: 10.1038/s41598-017-07903-4.
5
Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea.小鼠钠/肌醇共转运蛋白的缺失导致脑内肌醇耗竭和中枢性呼吸暂停。
J Biol Chem. 2003 May 16;278(20):18297-302. doi: 10.1074/jbc.M213176200. Epub 2003 Feb 11.
6
Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels.渗透调节性肌醇转运蛋白SMIT1通过调节磷脂酰肌醇-4,5-二磷酸(PI(4,5)P2)水平来调节电活动。
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):E3290-9. doi: 10.1073/pnas.1606348113. Epub 2016 May 23.
7
Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation.钠/肌醇共转运蛋白 1 和肌醇对成骨和骨形成至关重要。
J Bone Miner Res. 2011 Mar;26(3):582-90. doi: 10.1002/jbmr.240.
8
Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome).敲除肌醇转运蛋白 SMIT1 可使来自三体 16 胎鼠大脑皮层的永生化细胞系中的胆碱能和谷氨酸能功能正常化,三体 16 胎鼠是人类三体 21(唐氏综合征)的动物模型。
Neurotox Res. 2017 Nov;32(4):614-623. doi: 10.1007/s12640-017-9775-0. Epub 2017 Jul 10.
9
Identification of a novel Na+/myo-inositol cotransporter.一种新型钠/肌醇共转运体的鉴定。
J Biol Chem. 2002 Sep 20;277(38):35219-24. doi: 10.1074/jbc.M204321200. Epub 2002 Jul 19.
10
Glucose transporters in cardiovascular system in health and disease.心血管系统中的葡萄糖转运体:在健康和疾病中的作用。
Pflugers Arch. 2020 Sep;472(9):1385-1399. doi: 10.1007/s00424-020-02444-8. Epub 2020 Aug 18.

引用本文的文献

1
Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy.心脏钠-葡萄糖协同转运蛋白1(SGLT1)在糖尿病性心肌病小鼠模型中会导致心力衰竭。
Basic Res Cardiol. 2025 Sep 11. doi: 10.1007/s00395-025-01136-7.
2
Identification of potential biomarkers of triton WR-1339 induced hyperlipidemia: NMR-based plasma metabolomics approach and gene expression analysis.Triton WR-1339诱导的高脂血症潜在生物标志物的鉴定:基于核磁共振的血浆代谢组学方法及基因表达分析
Metabolomics. 2025 Sep 4;21(5):132. doi: 10.1007/s11306-025-02318-z.
3
SGLT2 Inhibitors: From Structure-Effect Relationship to Pharmacological Response.

本文引用的文献

1
Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells.钠葡萄糖协同转运蛋白2(SGLT2)作为一种生理性葡萄糖传感器,调节大鼠系膜细胞的细胞收缩性。
PLoS One. 2016 Mar 21;11(3):e0151585. doi: 10.1371/journal.pone.0151585. eCollection 2016.
2
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.钠葡萄糖协同转运蛋白SGLT1作为糖尿病的治疗靶点。
Expert Opin Ther Targets. 2016 Sep;20(9):1109-25. doi: 10.1517/14728222.2016.1168808. Epub 2016 Apr 12.
3
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂:从构效关系到药理反应
Int J Mol Sci. 2025 Jul 19;26(14):6937. doi: 10.3390/ijms26146937.
4
Genomic insights about the effect of sodium-glucose cotransporter 2 inhibitors: a systematic review.关于钠-葡萄糖协同转运蛋白2抑制剂作用的基因组学见解:一项系统综述。
Front Genet. 2025 May 30;16:1571032. doi: 10.3389/fgene.2025.1571032. eCollection 2025.
5
ApoE2 affects insulin signaling in the hippocampus and spatial cognition of aged mice in a sex-dependent manner.载脂蛋白E2以性别依赖的方式影响老年小鼠海马体中的胰岛素信号传导和空间认知。
Cell Commun Signal. 2025 Feb 26;23(1):112. doi: 10.1186/s12964-025-02093-3.
6
Anti-inflammatory Therapies for Ischemic Heart Disease.用于缺血性心脏病的抗炎疗法。
Curr Cardiol Rep. 2025 Feb 19;27(1):57. doi: 10.1007/s11886-025-02211-0.
7
Targeting Lactic Acid Modification in Ischemic Heart Diseases: Novel Therapeutics and Mechanism.靶向缺血性心脏病中的乳酸修饰:新型疗法与机制
J Cardiovasc Transl Res. 2025 Apr;18(2):257-267. doi: 10.1007/s12265-025-10593-3. Epub 2025 Feb 7.
8
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Guardians against Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Heart Diseases.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂:心脏病中线粒体功能障碍和内质网应激的守护者
ACS Pharmacol Transl Sci. 2024 Oct 16;7(11):3279-3298. doi: 10.1021/acsptsci.4c00240. eCollection 2024 Nov 8.
9
SGLT2 inhibitors protect against diabetic cardiomyopathy and atrial fibrillation through a CaMKII independent mechanism.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂通过一种不依赖钙调蛋白依赖性蛋白激酶II(CaMKII)的机制预防糖尿病性心肌病和心房颤动。
bioRxiv. 2024 Sep 23:2024.09.23.614368. doi: 10.1101/2024.09.23.614368.
10
Leveraging metabolism for better outcomes in heart failure.利用新陈代谢改善心力衰竭的治疗效果。
Cardiovasc Res. 2024 Dec 4;120(15):1835-1850. doi: 10.1093/cvr/cvae216.
恩格列净:在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
4
Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport.由于钠-葡萄糖协同转运增强,糖尿病心脏中的细胞内钠离子浓度([Na+]i)升高。
J Am Heart Assoc. 2015 Aug 27;4(9):e002183. doi: 10.1161/JAHA.115.002183.
5
Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.钠-葡萄糖协同转运蛋白SGLT1和SGLT2在人肾脏中的定位以及SGLT1在人小肠、肝脏、肺和心脏中的定位。
Pflugers Arch. 2015 Sep;467(9):1881-98. doi: 10.1007/s00424-014-1619-7. Epub 2014 Oct 11.
6
AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes.胰高血糖素样肽-1 通过激活 AMPK 防止高血糖诱导的成年心肌细胞中 NADPH 氧化酶的激活。
Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1120-33. doi: 10.1152/ajpheart.00210.2014. Epub 2014 Aug 15.
7
Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.在缺乏AMPKα1的小鼠中,瘢痕成熟和收缩性降低导致心肌梗死后左心室扩张加剧。
J Mol Cell Cardiol. 2014 Sep;74:32-43. doi: 10.1016/j.yjmcc.2014.04.018. Epub 2014 May 5.
8
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.胰岛素抵抗可保护心脏免受代谢失调状态下的燃料过载。
Am J Physiol Heart Circ Physiol. 2013 Dec;305(12):H1693-7. doi: 10.1152/ajpheart.00854.2012. Epub 2013 Oct 4.
9
Portal glucose influences the sensory, cortical and reward systems in rats.门冬氨酸葡萄糖影响大鼠的感觉、皮质和奖励系统。
Eur J Neurosci. 2013 Nov;38(10):3476-86. doi: 10.1111/ejn.12354. Epub 2013 Sep 8.
10
One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.根据糖化血红蛋白目标值,在二甲双胍的基础上加用利拉鲁肽,之后再换用胰岛素地特胰岛素,可实现 2 型糖尿病患者的 1 年持续血糖控制和体重减轻。
J Diabetes Complications. 2013 Sep-Oct;27(5):492-500. doi: 10.1016/j.jdiacomp.2013.04.008. Epub 2013 Jun 6.